Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors

Clinical trial NCT07584499 · RECRUITING

Trial details

NCT number: NCT07584499
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Nasopharyngeal Carcinoma Lymphoepithelial Carcinoma Rhabdomyosarcoma Neuroblastoma Medulloblastoma Wilms Tumor Atypical Teratoid/Rhabdoid Tumors Diffuse Intrinsic Pontine Gliomas Other EGFR-positive Pediatric Solid Tumors Deemed Eligible by the Investigator

Start date: 2026-05-30
Primary completion: 2027-05-30
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.